Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | Director | May 21, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date May 21, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 30,441 |
Reported balance
After 2026-05-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 30,441 · Balance 30,441 F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2: The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2: The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TEAM HEALTH HOLDINGS INC.
Report date February 06, 2017 · Filed February 08, 2017
Section 16 reporting ended · disclosed 2017-02-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-02-06 transaction · row 1
1 source rowRow 1 · 2017-02-06 · Disposition to issuer · Disposed 1,000 · Balance 0 F1: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-02-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-02-06 · Disposition to issuer · Disposed 723 · Balance 0 F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F4: These restricted stock units were to vest in two equal installments on the second and third anniversaries of the July 10, 2015 grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-02-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-02-06 · Disposition to issuer · Disposed 3,320 · Balance 0 F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F5: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 3, 2016 grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable withholding taxes.
F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
F3: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person.
F4: These restricted stock units were to vest in two equal installments on the second and third anniversaries of the July 10, 2015 grant date.
F5: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 3, 2016 grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 21, 2026 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 30,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001624004-26-000002 · wk-form4_1779398044.xml · derivative · entry 1 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,441 Underlying: Common Stock · 30,441 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| November 14, 2025 Filed Nov 17, 2025 21:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | PurchaseCommon Stock | 10,000 | $6.94 | $69,400.00 |
DisclosureSEC source: 0001624004-25-000006 · wk-form4_1763413502.xml · nonDerivative · entry 1 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,000 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 15, 2025. Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 28,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000067 · wk-form4_1748030773.xml · derivative · entry 1 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,986 Underlying: Common Stock · 28,986 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 22, 2026 and (ii) the day immediately preceding the issuer's 2026 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 22, 2026 and (ii) the day immediately preceding the issuer's 2026 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:28 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 17,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000130 · wk-form4_1716582475.xml · derivative · entry 1 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,467 Underlying: Common Stock · 17,467 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 23, 2025 and (ii) the day immediately preceding the issuer's 2025 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 23, 2025 and (ii) the day immediately preceding the issuer's 2025 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:33 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 9,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008854 · form4-05262023_080549.xml · derivative · entry 1 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,834 Underlying: Common Stock · 9,834 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 25, 2024 and (ii) the day immediately preceding the issuer's 2024 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 25, 2024 and (ii) the day immediately preceding the issuer's 2024 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 6,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005892 · form4-05312022_010527.xml · derivative · entry 1 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,726 Underlying: Common Stock · 6,726 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| May 17, 2021 Filed May 18, 2021 20:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 1,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005487 · edgar.xml · derivative · entry 1 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,638 Underlying: Common Stock · 1,638 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 17, 2022 and (ii) the day immediately preceding the issuer's 2022 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 17, 2022 and (ii) the day immediately preceding the issuer's 2022 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-20-007127 · edgar.xml · derivative · entry 3 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,565 Underlying: Common Stock · 10,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual installments beginning March 3, 2018. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 10,000 | $160.00 | $1,600,000.00 |
DisclosureSEC source: 0001179110-20-007127 · edgar.xml · nonDerivative · entry 2 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 10,000 | $22.30 | $223,000.00 |
DisclosureSEC source: 0001179110-20-007127 · edgar.xml · nonDerivative · entry 1 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 1,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006749 · edgar.xml · derivative · entry 1 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,049 Underlying: Common Stock · 1,049 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 28, 2021 and (ii) the day immediately preceding the issuer's 2021 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's DeferredCompensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 28, 2021 and (ii) the day immediately preceding the issuer's 2021 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's DeferredCompensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 3,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006973 · edgar.xml · derivative · entry 1 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,012 Underlying: Common Stock · 3,012 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 30, 2020 and (ii) the day immediately preceding the issuer's 2020 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 30, 2020 and (ii) the day immediately preceding the issuer's 2020 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 21:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-007972 · edgar.xml · derivative · entry 2 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,965 Underlying: Common Stock · 1,965 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F1 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 31, 2019 and (ii) the day immediately preceding the issuer's 2019 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F1 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 31, 2019 and (ii) the day immediately preceding the issuer's 2019 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 21:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantStock Option (right to buy) · Derivative | 4,082 | $0.00 Strike: $50.90 | $0.00 |
DisclosureSEC source: 0001179110-18-007972 · edgar.xml · derivative · entry 1 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,082 Underlying: Common Stock · 4,082 shares Expires 2028-05-31 F2 · derivative.exercise_date: The option vests in full on the earlier of (i) May 31, 2019 and (ii) the day immediately preceding the issuer's 2019 annual meeting of stockholders. Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 23:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantStock Option (right to buy) · Derivative | 20,565 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-17-004044 · edgar.xml · derivative · entry 1 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,565 Underlying: Common Stock · 20,565 shares Expires 2027-03-03 F1 · derivative.exercise_date: The option will vest in three equal, annual installments beginning on March 3, 2018. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 20:25 UTC | TEAM HEALTH HOLDINGS INC. TMH · Entity 16682 | Disposition to issuerRestricted Stock Units · Derivative | 3,320 | $43.50 | $144,420.00 |
DisclosureSEC source: 0000899243-17-003188 · doc4.xml · derivative · entry 3 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,320 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · kind: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F3 · price: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F5 · derivative.exercise_date: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 3, 2016 grant date. F5 · derivative.expiration_date: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 3, 2016 grant date. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 20:25 UTC | TEAM HEALTH HOLDINGS INC. TMH · Entity 16682 | Disposition to issuerRestricted Stock Units · Derivative | 723 | $43.50 | $31,450.50 |
DisclosureSEC source: 0000899243-17-003188 · doc4.xml · derivative · entry 2 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 723 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · kind: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F3 · price: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F4 · derivative.exercise_date: These restricted stock units were to vest in two equal installments on the second and third anniversaries of the July 10, 2015 grant date. F4 · derivative.expiration_date: These restricted stock units were to vest in two equal installments on the second and third anniversaries of the July 10, 2015 grant date. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 20:25 UTC | TEAM HEALTH HOLDINGS INC. TMH · Entity 16682 | Disposition to issuerCommon Stock | 1,000 | $43.50 | $43,500.00 |
DisclosureSEC source: 0000899243-17-003188 · doc4.xml · nonDerivative · entry 1 Paulus Kenneth H · CIK 0001624004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable withholding taxes. F1 · price: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable withholding taxes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.